维普期刊资源整合服务平台（V6.5）

109篇 您的检索式：作者名="List AF"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia : a Southwest Oncology Group study 显示文摘	List AF Kopecky KJ Willman CL	2001	Blood2001，98，12：	1
2	Phase Ⅰ/Ⅱ trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia显示文摘	List AF Spier C Greer John	1993	J Clin Oncol1993，11，9：	1
3	New approaches to the treatment of myelodysplasia 显示文摘	List AF	2002	Oncologist2002，7，：	1
4	Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration显示文摘	List AF Gonzalez-Osete G Kummet T	1991	American journal of medicine1991，90，2：	1
5	Chemotherapy resistance in acute myeloid leukaemia显示文摘	Sonneveld P List AF		0，，：	1
6	Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leuke -mia and myelodysplastic syndrome显示文摘	Roboz GJ Giles FJ List AF	2006	Leukemia2006，20，6：	1
7	Phase Ⅰ/Ⅱ trial of Cyclosporine as a chemotherapy resistance modifier in acute leukemia显示文摘	List AF Spier C Greer J	1993	J Clin Oncol1993，11，：	1
8	Phase Ⅰ/Ⅱ trial of cyclosporine as a chemotherapy resistance modifier in acute leukaemia显示文摘	Spier C Greer J	1993	J Clin Oncol1993，11，9：	1
9	Cytokine targets in the treatment of myelodysplastic syndromes显示文摘	Verma A List AF	2005	Curr Hematol Rep2005，4，6：	1
10	Benefit of cyclosporine modulation of drug resistance in atpients with poor-risk acute myeloid leukemia:a Southwest Oncology Group Study显示文摘	List AF Kopecky KJ Willman CL	2001	Blood2001，98，：	1
11	Rloe of multidrug resistance and its pharuacological modulation in acute myeloid leukemia 显示文摘	List AF	1996	Leukemia1996，10，6：	1
12	Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia显示文摘	List AF Spier CS Grogan TM	1996	Blood1996，87，：	1
13	Myelodysplastic syndromes显示文摘	Vardiman J Issa JP	2004	Hematology (Am Soc Hematol Educ Program)2004，，：	1
14	Benefit of cyclosporine modulation of drug resistance in patient with poor-risk acute myeloid leukemia:a South-west Oneology Group study显示文摘	Kopecky KJ Willman CL	2001	Blood2001，98，12：	1
15	Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del (5q) myelodysplastic syndromes显示文摘	Komrokji RS List AF	2016	Ann Oncol2016，27，1：	1
16	Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes显示文摘	Sekeres MA List AF Cuthbertson D	2010	J Clin Oncol2010，28，13：	1
17	Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia显示文摘	List AF	1996	Leukemia1996，10，6：	1
18	Targeting the multidrug resistance-1 transporter in AML:molecular regulation and therapeutic strategies显示文摘	MAHADEVAN D LIST AF	2004	Blood2004，104，7：	1
19	Amifostlne: a tonic or toxin to myeloid pro- genitors 显示文摘	List AF Gerner EW	2000	Leuk Res2000，24，12：	1
20	Phase Ⅰ/Ⅱ trial of cyclosporine as achemotherapy resistance modifier in acute leukemia 显示文摘	List AF Spier C Grear J	1993	J Clin Oncol1993，11，9：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示